As of 2026-03-13, the Relative Valuation of Talis Biomedical Corp (TLIS) is (72.96) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.84 USD, the upside of Talis Biomedical Corp based on Relative Valuation is -2669.0%.
The range of the Relative Valuation is (61.63) - (75.00) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 18.4x - 31.8x | 27.4x |
| Forward P/E multiples | 21.6x - 26.2x | 23.7x |
| Fair Price | (61.63) - (75.00) | (72.96) |
| Upside | -2269.9% - -2741.0% | -2669.0% |
| Date | P/E |
| 2025-12-18 | -0.99 |
| 2025-12-17 | -0.56 |
| 2025-12-15 | -0.56 |